Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Ausper Biopharma Co., Ltd. clinical trials
The registry lists 14 studies whose lead sponsor is Ausper Biopharma Co., Ltd.. 9 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 21, 2026.
Keep track of what changes. Save the Ausper Biopharma Co., Ltd. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesWhere
- China
- 13
Registry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Ausper Biopharma Co., Ltd..
- Ausper Biopharma Co., Ltd.14 studiesSame company
Something wrong?
Focus areas
Conditions Ausper Biopharma Co., Ltd. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 14 of 14.
- A Clinical Study of AHB-121 in Healthy Participants and Chronic Hepatitis B (CHB) ParticipantsNot yet recruitingNCT07884864Phase 1
- A Study of Sequential Therapy With AHB-137 Injection Followed by TVAX-008 Injection in Participants Living With Chronic Hepatitis B (CHB)Not yet recruitingNCT07876856Phase 1/2
- Long-term Follow-up Study to Evaluate Participants With Chronic Hepatitis B (CHB) Previously Treated With AHB-137 InjectionRecruitingNCT07146100
- A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)RecruitingNCT07137910Phase 2
- A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function.RecruitingNCT07600788Phase 1
- A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B DrugsRecruitingNCT07069569Phase 2
- A Study to Evaluate AHB-137 Injection in Treatment-naïve Participants With Chronic Hepatitis BRecruitingNCT07635186Phase 2
- Study of AHB-171 in Chronic Hepatitis B ParticipantsRecruitingNCT07630727Phase 2
- A Phase I Clinical Study of AHB - 171 in Healthy Participants(HP) and Chronic Hepatitis B (CHB) ParticipantsRecruitingNCT07511218Phase 1
- Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB).CompletedNCT06550128Phase 2
- A Study to Evaluate the Antiviral Activity and Immune Response of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)Active, not recruitingNCT06993480Phase 2
- Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB)Active, not recruitingNCT06829329Phase 2
- A Study to Evaluate the Safety and Efficacy of AHB-137 in Healthy Participants and HBeAg-negative Chronic Hepatitis B (CHB) PatientsCompletedNCT06115993Phase 1/2
- Study of AHB-137 in Participants With Chronic Hepatitis B (CHB) Treated With Nucleos(t)Ide Analogues (NAs)(AUSHINE)Active, not recruitingNCT07246889Phase 3